✦ LIBER ✦

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

✍ Scribed by Ogawa, Eiichi; Furusyo, Norihiro; Kajiwara, Eiji; Takahashi, Kazuhiro; Nomura, Hideyuki; Tanabe, Yuichi; Satoh, Takeaki; Maruyama, Toshihiro; Nakamuta, Makoto; Kotoh, Kazuhiro; Azuma, Koichi; Dohmen, Kazufumi; Shimoda, Shinji; Hayashi, Jun

Book ID: 118792412
Publisher: Springer
Year: 2012
Tongue: English
Weight: 206 KB
Volume: 18
Category: Article
ISSN: 1341-321X
DOI: 10.1007/s10156-012-0396-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ribavirin dose reduction raises relapse

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

✍ N. Hiramatsu; T. Oze; T. Yakushijin; Y. Inoue; T. Igura; K. Mochizuki; K. Imanak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Pharmacokinetics and enhanced PKR respon

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin

✍ Y. Asahina; N. Izumi; N. Umeda; T. Hosokawa; K. Ueda; F. Doi; K. Tsuchiya; H. Na 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB

The longitudinal quantitative assessment

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

✍ Eiichi Ogawa; Norihiro Furusyo; Kazuhiro Toyoda; Hiroaki Takeoka; Shinji Maeda; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 617 KB

Impact of ribavirin plasma level on sust

Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C

✍ D. BREILH; J. FOUCHER; L. CASTÉRA; P. TRIMOULET; S. DJABAROUTI; W. MERROUCHE; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Pegylated interferon alpha-2b plus ribav

Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response

✍ Sanaa M. Kamal; Samer S. El Kamary; Michelle D. Shardell; Mohamed Hashem; Imad N 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

In patients chronically infected with hepatitis C virus (HCV) genotype 4, the optimum duration of therapy and the predictors of sustained virologic response (SVR) have not been adequately determined. In this study, 358 patients with chronic hepatitis C genotype 4 were randomly assigned to pegylated

PA.104 PREDICTORS OF SUSTAINED VIROLOGIC

PA.104 PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN

✍ M. Paci; E. Lorefice; E. Gianni; S. Renzo; M. Capanni; P. Forte; S. Milani; C. S 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB